All markers significantly distinguished healthy subjects and BC cases: CD3, CD25, CD56 (p < 0.001); CD2, CD9, CD142, and CD14 (p < 0.01); CD44, CD326, CD133/1, and CD45 (p < 0.05). The gene discussed is PTPRC; the disease is breast cancer.